Literature DB >> 8332631

A comparison of the motor-activating effects of acute and chronic exposure to amphetamine and methylphenidate.

C G McNamara1, E S Davidson, S Schenk.   

Abstract

Acute exposure to methylphenidate (0.0, 5.0, 10.0, or 20.0 mg/kg) or amphetamine (0.0, 0.5, 1.0, 2.0, or 4.0 mg/kg) dose-dependently increased horizontal activity. The amphetamine-induced increase in activity was progressively augmented with repeated exposures over 7 days. In contrast, methylphenidate (20.0 mg/kg)-induced increases in activity became smaller with repeated exposures. Subthreshold doses of methylphenidate (1.0 or 5.0 mg/kg) were ineffective in stimulating motor activity even after 7 daily exposures. These findings suggest that, although sensitization develops with chronic amphetamine treatment, the consequence of chronic exposure to methylphenidate is tolerance. These data are discussed in terms of the different mechanisms through which methylphenidate and amphetamine affect central dopamine release.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8332631     DOI: 10.1016/0091-3057(93)90532-x

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  11 in total

1.  Acute and long-term effects of adolescent methylphenidate on decision-making and dopamine receptor mRNA expression in the orbitofrontal cortex.

Authors:  Leslie R Amodeo; Eliza Jacobs-Brichford; Matthew S McMurray; Jamie D Roitman
Journal:  Behav Brain Res       Date:  2017-02-14       Impact factor: 3.332

2.  A novel strategy for dissecting goal-directed action and arousal components of motivated behavior with a progressive hold-down task.

Authors:  Matthew R Bailey; Greg Jensen; Kathleen Taylor; Chris Mezias; Cait Williamson; Rae Silver; Eleanor H Simpson; Peter D Balsam
Journal:  Behav Neurosci       Date:  2015-06       Impact factor: 1.912

3.  Repeated administration of methylphenidate in young, adolescent, and mature rats affects the response to cocaine later in adulthood.

Authors:  Annelyn Torres-Reverón; Diana L Dow-Edwards
Journal:  Psychopharmacology (Berl)       Date:  2005-10-15       Impact factor: 4.530

4.  Chronic administration of methylphenidate produces neurophysiological and behavioral sensitization.

Authors:  Pamela B Yang; Alan C Swann; Nachum Dafny
Journal:  Brain Res       Date:  2007-02-02       Impact factor: 3.252

5.  Developmental Deltamethrin Exposure Causes Persistent Changes in Dopaminergic Gene Expression, Neurochemistry, and Locomotor Activity in Zebrafish.

Authors:  Tiffany S Kung; Jason R Richardson; Keith R Cooper; Lori A White
Journal:  Toxicol Sci       Date:  2015-04-24       Impact factor: 4.849

6.  Exposure of adolescent rats to oral methylphenidate: preferential effects on extracellular norepinephrine and absence of sensitization and cross-sensitization to methamphetamine.

Authors:  Ronald Kuczenski; David S Segal
Journal:  J Neurosci       Date:  2002-08-15       Impact factor: 6.167

7.  Effects of acute doses of methylphenidate on inflammation and oxidative stress in isolated hippocampus and cerebral cortex of adult rats.

Authors:  Majid Motaghinejad; Manijeh Motevalian; Behnaz Shabab; Sulail Fatima
Journal:  J Neural Transm (Vienna)       Date:  2016-09-28       Impact factor: 3.575

8.  Early ontogeny of D-amphetamine-induced one-trial behavioral sensitization.

Authors:  Sanders A McDougall; Charlotte M Nuqui; Anthony T Quiroz; Carrissa M Martinez
Journal:  Pharmacol Biochem Behav       Date:  2013-01-27       Impact factor: 3.533

9.  Dissociable rate-dependent effects of oral methylphenidate on impulsivity and D2/3 receptor availability in the striatum.

Authors:  Daniele Caprioli; Bianca Jupp; Young T Hong; Stephen J Sawiak; Valentina Ferrari; Laura Wharton; David J Williamson; Carolyn McNabb; David Berry; Franklin I Aigbirhio; Trevor W Robbins; Tim D Fryer; Jeffrey W Dalley
Journal:  J Neurosci       Date:  2015-03-04       Impact factor: 6.167

10.  Long-term stimulant treatment affects brain dopamine transporter level in patients with attention deficit hyperactive disorder.

Authors:  Gene-Jack Wang; Nora D Volkow; Timothy Wigal; Scott H Kollins; Jeffrey H Newcorn; Frank Telang; Jean Logan; Millard Jayne; Christopher T Wong; Hao Han; Joanna S Fowler; Wei Zhu; James M Swanson
Journal:  PLoS One       Date:  2013-05-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.